Clinical Response Difference between Acyclovir and Valacyclovir in Recurrent Intraoral Herpes: Adaptation Treatment in Pandemic Situation
DOI:
https://doi.org/10.35790/eg.v10i1.39267Abstract
Abstract: Recurrent intraoral herpes (RIH) is a reactivation of herpes simplex virus 1 (HSV 1) and is treated with an antiviral. In this pandemic situation, limited access to health care may lead to many consequences. This case report reports the difference in clinical response between acyclovir and valacyclovir in RIH and treatment in the pandemic situation. A 24 years old man complained of ulcers and pain in the mouth in the last two weeks. The patient had a history of recurrent ulcers since a year ago. Intraoral examination showed multiple ulcers, with erythema halo, 0.2-0.3 cm in diameters on the tongue, uvula, and pharynx. The patient had difficulty in eating. The IgG anti-HSV 1 test showed a positive result, and the lesions were diagnosed as RIH. The patient was treated with acyclovir, benzylamine HCl, and vitamin B12. One month after treatment, the lesions improved, but new lesions still emerged. Therefore, valacyclovir was substituted for acyclovir. Since the patient had difficulty in going to the hospital due to the lockdown policy, medication for two weeks was prescribed for him. One month after treatment with valacyclovir, there was no more new lesion emerging. In conclusion, there was a difference in clinical response between acyclovir and valacyclovir. It is assumed that the patient has resistancy to acyclovir which resulting in poor improvement. The pandemic condition forces us to be flexible in handling patients and adapting to government conditions and rules.
Keywords: recurrent intraoral herpes; acyclovir; valacyclovir
Downloads
Additional Files
- Surat Pernyataan Bebas Plagiarisme
- Figure 1. Multiple ulcers on the tongue (a) and pharynx (b) at the first visit.
- Figure 2. Second visit. Healing of the right lateral tongue (a) and pharynx (b) at the second visit. New ulcer on the left lateral tongue (c)
- Figure 3. Third visit. Ulcer on the left lateral tongue (a) has not yet healed, and a new ulcer appears on the lower lip mucosa (b).
- Figure 4. In fourth visit, the lesion on the left lateral tongue healed (a) and a new ulcer appeared on the right buccal mucosa (b)
- Figure 5. After using valacyclovir, there were no lesions on the lower labial mucosa (a), left lateral tongue (b), and right buccal mucosa (c) at the fifth visit.
Published
How to Cite
Issue
Section
License
COPYRIGHT
Authors who publish with this journal agree to the following terms:
Authors hold their copyright and grant this journal the privilege of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that permits others to impart the work with an acknowledgment of the work's origin and initial publication by this journal.
Authors can enter into separate or additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (for example, post it to an institutional repository or publish it in a book), with an acknowledgment of its underlying publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their website) as it can lead to productive exchanges, as well as earlier and greater citation of the published work (See The Effect of Open Access).
